134 related articles for article (PubMed ID: 16802773)
1. Effect of a Chinese herbal formula, Shi-Bi-Lin, on an experimental model of allergic rhinitis.
Zhao Y; van Hasselt CA; Woo JK; Chen GG; Wong YO; Wang LH; Leung PC
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):844-50. PubMed ID: 16802773
[TBL] [Abstract][Full Text] [Related]
2. [The effect of desloratadine on the TXB2 and leukotrienes levels in the nasal lavage fluid of allergic rhinitis animal model].
Zhao Y; Van Hasselt CA; Woo K; Wong Y; Leung P
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(8):365-7. PubMed ID: 16075993
[TBL] [Abstract][Full Text] [Related]
3. Treatment of perennial allergic rhinitis using Shi-Bi-Lin, a Chinese herbal formula.
Zhao Y; Woo KS; Ma KH; van Hansselt CA; Wong KC; Cheng KF; Lam CW; Leung PC
J Ethnopharmacol; 2009 Feb; 122(1):100-5. PubMed ID: 19118617
[TBL] [Abstract][Full Text] [Related]
4. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
Lieber G; Jimenez J; Hunter JC; McLeod RL; Jia Y
Pharmacology; 2010; 85(5):311-8. PubMed ID: 20453555
[TBL] [Abstract][Full Text] [Related]
5. No involvement of interleukin-5 or eosinophils in experimental allergic rhinitis in guinea pigs.
Yamasaki M; Mizutani N; Sasaki K; Nabe T; Kohno S
Eur J Pharmacol; 2002 Mar; 439(1-3):159-69. PubMed ID: 11937106
[TBL] [Abstract][Full Text] [Related]
6. Role of hematopoietic prostaglandin D synthase in biphasic nasal obstruction in guinea pig model of experimental allergic rhinitis.
Kajiwara D; Aoyagi H; Shigeno K; Togawa M; Tanaka K; Inagaki N; Miyoshi K
Eur J Pharmacol; 2011 Sep; 667(1-3):389-95. PubMed ID: 21645503
[TBL] [Abstract][Full Text] [Related]
7. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model.
Akiyama K; Karaki M; Kobayshi R; Dobashi H; Ishida T; Mori N
Int Arch Allergy Immunol; 2009; 149(4):315-22. PubMed ID: 19295235
[TBL] [Abstract][Full Text] [Related]
8. Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H.
Mandhane SN; Shah JH; Bahekar PC; Mehetre SV; Pawar CA; Bagad AS; Chidrewar GU; Rao CT; Rajamannar T
Int Arch Allergy Immunol; 2010; 151(1):56-69. PubMed ID: 19672097
[TBL] [Abstract][Full Text] [Related]
9. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis.
Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X
Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271
[TBL] [Abstract][Full Text] [Related]
11. The role of chemical mediators in eosinophil infiltration in allergic rhinitis in mice.
Kayasuga R; Iba Y; Hossen MA; Watanabe T; Kamei C
Int Immunopharmacol; 2003 Apr; 3(4):469-73. PubMed ID: 12689652
[TBL] [Abstract][Full Text] [Related]
12. Effect of olopatadine hydrochloride, an anti-histamine drug, on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
Tamura T; Komai M
Int Immunopharmacol; 2008 Jun; 8(6):916-21. PubMed ID: 18442798
[TBL] [Abstract][Full Text] [Related]
13. Suppression of allergic response by CpG motif oligodeoxynucleotide-house-dust mite conjugate in animal model of allergic rhinitis.
Mo JH; Park SW; Rhee CS; Takabayashi K; Lee SS; Quan SH; Kim IS; Min IY; Raz E; Lee CH
Am J Rhinol; 2006; 20(2):212-8. PubMed ID: 16686392
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an allergic rhinitis model in mice for the evaluation of nasal symptoms.
Tsunematsu M; Yamaji T; Kozutsumi D; Murakami R; Kimura S; Kino K
Life Sci; 2007 Mar; 80(15):1388-94. PubMed ID: 17300813
[TBL] [Abstract][Full Text] [Related]
15. Effects of the Chinese herbal formula Shi-Bi-Lin on cytokine release from the human mast cell line.
Zhao Y; van Hasselt CA; Woo JK; Chen GG; Wong YO; Wang LH; Leung PC
Ann Allergy Asthma Immunol; 2005 Jul; 95(1):79-85. PubMed ID: 16095146
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic and pathophysiological observations in a modified animal model of allergic rhinitis.
Zhao Y; Woo JK; Leung PC; Chen GG; Wong YO; Liu SX; van Hasselt CA
Rhinology; 2005 Mar; 43(1):47-54. PubMed ID: 15844502
[TBL] [Abstract][Full Text] [Related]
17. [Effect and mechanism of bishudiwan(BSDW) against allergy].
Zhang M; Ren Y; Song CS; Zhao FZ; Hu DB; Guo J; Yan CW; Dai X; Yang JD; Shun HX
Zhongguo Zhong Yao Za Zhi; 2003 Jun; 28(6):540-4. PubMed ID: 15015336
[TBL] [Abstract][Full Text] [Related]
18. [The immunohistochemical observations of NOS in the nasal mucosa of allergic rhinitis animal model of guinea pigs].
Zhao Y; Van Hasselt CA; Woo K; Wong Y; Leung P
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Mar; 19(5):219-21. PubMed ID: 15934291
[TBL] [Abstract][Full Text] [Related]
19. Desloratadine partially inhibits the augmented bacterial responses in the sinuses of allergic and infected mice.
Kirtsreesakul V; Blair C; Yu X; Thompson K; Naclerio RM
Clin Exp Allergy; 2004 Oct; 34(10):1649-54. PubMed ID: 15479283
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic effects of the histamine H1 receptor antagonist epinastine and the dual thromboxane A2 receptor and chemoattractant receptor-homologous molecule expressed on Th2 cells antagonist ramatroban on allergic rhinitis model in mice.
Suzuki Y; Inoue T; Yamamoto A; Sugimoto Y
Biol Pharm Bull; 2011; 34(4):507-10. PubMed ID: 21467637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
